Crafting a compelling neurotech pitch requires more than groundbreaking science—it demands strong data, clear metrics, and a well-structured narrative. Investors look for statistically relevant datasets, proper controls, and thoughtful study design to evaluate potential. Beyond the technology, a scalable business model and strategic milestones are essential for securing funding. Join us as we explore key insights on building a data-driven pitch that resonates with investors.